Annette F. Favorite
Known title: Sr. VP Human Resources OfficerCIK: 0001654975
Associated companies
Transaction History
| WST | ▲ Buy | Option Exercise | 2,524 | $226K | 9/15/2026 | View on chart |
| WST | ▼ Sell | Open Market | 2,524 | $921K | 9/15/2026 | View on chart |
| WST | ▲ Buy | Option Exercise | 2,500 | $224K | 9/14/2026 | View on chart |
| WST | ▼ Sell | Open Market | 2,500 | $888K | 9/14/2026 | View on chart |
| WST | ▲ Buy | Option Exercise | 2,500 | $224K | 9/11/2026 | View on chart |
| WST | ▼ Sell | Open Market | 2,500 | $863K | 9/11/2026 | View on chart |
| WST | ▲ Buy | Option Exercise | 2,817 | $235K | 9/8/2026 | View on chart |
| WST | ▲ Buy | Option Exercise | 2,500 | $224K | 9/8/2026 | View on chart |
| WST | ▼ Sell | Open Market | 2,500 | $852K | 9/8/2026 | View on chart |
| WST | ▼ Sell | Open Market | 2,817 | $960K | 9/8/2026 | View on chart |
| WST | ▲ Buy | Option Exercise | 2,818 | $235K | 9/8/2026 | View on chart |
| WST | ▼ Sell | Open Market | 2,818 | $960K | 9/8/2026 | View on chart |
| WST | ▼ Sell | Open Market | 2,817 | $860K | 4/27/2026 | View on chart |
| WST | ▲ Buy | Option Exercise | 2,817 | $235K | 4/27/2026 | View on chart |
| WST | ▲ Buy | Option Exercise | 135 | — | 2/18/2026 | View on chart |
| WST | ▼ Sell | Tax Withholding | 36 | $9K | 2/18/2026 | View on chart |
| WST | ▲ Buy | Grant | 442 | $0 | 2/17/2026 | View on chart |
| WST | ▼ Sell | Tax Withholding | 150 | $37K | 2/17/2026 | View on chart |
| WST | ▲ Buy | Option Exercise | 246 | $52K | 2/18/2025 | View on chart |
| WST | ▼ Sell | Tax Withholding | 84 | $18K | 2/18/2025 | View on chart |
| WST | ▲ Buy | Grant | 541 | $0 | 2/20/2024 | View on chart |
| WST | ▼ Sell | Gift | 584 | $0 | 12/11/2023 | View on chart |
| WST | ▲ Buy | Option Exercise | 2,000 | $167K | 8/30/2023 | View on chart |
| WST | ▼ Sell | Open Market | 760 | $315K | 8/30/2023 | View on chart |
| WST | ▼ Sell | Open Market | 1,240 | $514K | 8/30/2023 | View on chart |
| WST | ▼ Sell | Open Market | 2,687 | $985K | 5/1/2023 | View on chart |
| WST | ▼ Sell | Open Market | 900 | $331K | 5/1/2023 | View on chart |
| WST | ▲ Buy | Option Exercise | 13,012 | $776K | 5/1/2023 | View on chart |
| WST | ▼ Sell | Open Market | 9,425 | $3.4M | 5/1/2023 | View on chart |
| WST | ▲ Buy | Grant | 1,740 | $534K | 2/21/2023 | View on chart |
| WST | ▲ Buy | Grant | 2,490 | $919K | 2/22/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
West Pharmaceutical Services noted in analyst upgrade and market rally
West Pharmaceutical Services has risen about 36% year-to-date, drawing attention in recent market round-ups. TD Cowen kept its positive stance and lifted its price target to $420, citing the company's performance. The stock also appeared in CNBC’s final‑trade segment and in a dividend‑growth stock list, highlighting investor interest.
West Pharmaceutical Services noted in analyst upgrade and market rally. West Pharmaceutical Services has risen about 36% year-to-date, drawing attention in recent market round-ups. TD Cowen kept its positive stance and lifted its price target to $420, citing the company's performance. The stock also appeared in CNBC’s final‑trade segment and in a dividend‑growth stock list, highlighting investor interest.